(Q38139603)

29 August 2017

0 references

Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits (English)

1 reference

29 August 2017

1 reference

1

Günther Deuschl

0 references

Yves Agid

series ordinal

2

object named as

Yves Agid

1 reference

29 August 2017

publication date

1 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

1025-1034

1 reference

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Clinical predictive factors of subthalamic stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Predictors of effective bilateral subthalamic nucleus stimulation for PD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neurostimulation for Parkinson's Disease with Early Motor Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Parkinson disease: deep brain stimulation in Parkinson disease-what went wrong?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term outcomes of surgical therapies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Progression of Parkinson's disease in the clinical phase: potential markers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA-Psychosocial questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term surgical and hardware-related complications of deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Risk of surgical delivery to deep nuclei: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Intracerebral infections as a complication of deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Thirty days complication rate following surgery performed for deep-brain-stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

An evaluation of hardware and surgical complications with deep brain stimulation based on diagnosis and lead location

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Hardware complications in deep brain stimulation: electrode impedance and loss of clinical benefit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Deep brain stimulation: neuropsychological and neuropsychiatric issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Deep brain stimulation: from neurology to psychiatry?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Electrode dysfunctions in patients with deep brain stimulation: a clinical retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Basic algorithms for the programming of deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neurosurgery in Parkinson disease: A distressed mind in a repaired body?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

The natural history of multiple system atrophy: a prospective European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Glutathione peroxidase, glial cells and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Milestones in research on the pathophysiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Instruments for holistic assessment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Late-stage Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

A second honeymoon for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970151-0

7 January 2021

10.1016/S1474-4422(13)70151-0

Identifiers

DOI

1 reference

29 August 2017

1 reference